Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

XGN

Exagen (XGN)

Exagen Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XGN
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202402h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
14/05/202422h25AllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
13/05/202415h30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
13/05/202415h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
13/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
13/05/202414h00GlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
06/05/202422h05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
30/04/202422h05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
26/04/202414h30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
18/03/202413h00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
18/03/202412h12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
08/03/202415h00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
07/03/202422h05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
06/03/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
04/03/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
22/02/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
22/02/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
14/02/202413h12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
13/02/202422h35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
08/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
02/02/202421h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
30/01/202422h05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
22/01/202422h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
08/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
07/01/202418h00GlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
11/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
30/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
29/11/202323h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
27/11/202322h05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
20/11/202314h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN